don't take it from me take it from the bangle ceo of alkermes.e about his company and where it is headed, welcome back to "mad money." good to see you, sir. have a seat. until i saw the news about the multiple sclerosis, i just thought that the depression drugs are huge. but let's do ms. because one of the reasons i want to do it is immediately after the note comes out about yours, the biogen people say don't worry about it. this has a much better safety profile than the established $2.9 billion drug out there. >> we'll see. first of all, i have to say happy birthday. >> thank you very much. >> that's most important today. >> i see richard outside. but there is clauses that richard's involved in that i'm involved in that are the same. there is a mutuality beyond the stock. >> as it relates to this multiple sclerosis drug, biogen net tick's drug is a wonderful drug. it does have liabilities in terms of side effects. our goal was to make a drug even better tolerated for people taking this drug long-term. >> gi tract. >> gi tract. we made a new mole